MedTrace Logo

Comparison of Clinical Efficacy of a Dentifrice Containing 5% Fluoro Calcium Phosphosilicate to a Dentifrice Containing Calcium Sodium Phosphosilicate on Dentinal Hypersensitivity

NCT03741309 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 131

Last updated 2018-11-14

No results posted yet for this study

Summary

Aim of this study was to assess and compare the efficacy of a dentifrice containing 5% fluoro calcium phosphosilicate and dentifrice containing calcium sodium phosphosilicate on Dentinal Hypersensitivity (DH) compared to a placebo over a period of 6 weeks.

Conditions

  • Dentinal Hypersensitivity

Interventions

OTHER

5% fluorocalcium phosphosilicate dentifrice

dentifrice containing 5% fluorocalcium phosphosilicate and VAS score assessed at Baseline, 2 weeks, 6 weeks.

OTHER

Calcium sodium phosphosilicate

Calcium sodium phosphosilicatand VAS score assessed at Baseline, 2weeks, 6 weeks.

OTHER

Placebo dentrifice

placebo dentifrice and VAS score assessed at Baseline, 2weeks, 6 weeks.

Sponsors & Collaborators

  • Group Pharma

    collaborator OTHER

  • Government Dental College and Research Institute, Bangalore

    lead OTHER

Principal Investigators

  • Avani R Pradeep, MDS · GDCRI, Bangalore, INDIA

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-20
Primary Completion
2018-02-16
Completion
2018-02-24

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03741309 on ClinicalTrials.gov